FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | Sample | Privacy
Related Topics >> Genzyme | drug prices

The world's most expensive drugs

Free Newsletter

FiercePharma Manufacturing provides must-know news and insight on the hardware and software tools used to automate pharmaceutical manufacturing. Sign up today to receive your FREE "insiders only" weekly pharma manufacturing industry briefing.



Tools

Genzyme drugs take four spots among the most expensive in a Forbes survey (chart). The developer's rare disease treatments Myozyme, Fabrazyme, Cerezyme and Aldurazyme all cost over $200,000 per year. But the Cerezyme price is likely to head south following last week's FDA approval of Shire's Gaucher treatment, velaglucerase alfa for injection. Alexion Pharmaceuticals takes the top spot for the world's most expensive drug, Soliris. The therapy costs $409,500 per year. Chart | Article | Genzyme release


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Manufacturing Email Newsletter:

More stories about Genzyme   drug prices